Evaluating in Vivo Efficacy - Toxicity Profile of Teg001 in Humanized Mice Xenografts Against Primary Human Aml Disease and Healthy Hematopoietic Cells

AuthID
 P-00Q-BPD
9
Author(s)
Johanna, I
·
Aarts Riemens, T
·
Norell, H
·
Bongiovanni, L
·
de Bruin, A
·
Sebestyen, Z
·
Document Type
Article
Year published
2019
Published
in JOURNAL FOR IMMUNOTHERAPY OF CANCER, ISSN: 2051-1426
Volume: 7, Issue: 1
Indexing
Wos®
Scopus®
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 30871629
Scopus: 2-s2.0-85062996684
Wos: WOS:000461340900001
Source Identifiers
ISSN: 2051-1426
Export Publication Metadata
Marked List
 Add to Marked List
Citations
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2026 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service